Jagotec AG
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
5
Ending by 2030
Aug 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 11, 2027The maintenance fee for Controlled Release Nisoldipine Compositions (US 9,101,544) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Medicinal Aerosol Formulations (US 10,471,077) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Jun 22, 2027The maintenance fee for Chewing gum in the form of multi-layer tablets (US 9,216,157) comes due Jun 22, 2027. Unpaid by Dec 22, 2027, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Floating Gastric Retentive Dosage Form (US 9,314,430) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,622,980 | Controlled Release Compositions In force · High confidence | In force | High confidence | |
| US 8,168,218 | Delayed Release Tablet with Defined Core Geometry In force · High confidence | In force | High confidence | |
| US 9,101,544 | Controlled Release Nisoldipine Compositions In force · High confidence | In force | High confidence | |
| US 9,216,157 | Chewing gum in the form of multi-layer tablets In force · High confidence | In force | High confidence | |
| US 10,471,077 | Medicinal Aerosol Formulations In force · High confidence | In force | High confidence | |
| US 10,076,500 | Floating Gastric Retentive Dosage Form In force · High confidence | In force | High confidence | |
| US 9,314,430 | Floating Gastric Retentive Dosage Form In force · High confidence | In force | High confidence | |
| US 9,849,097 | Dosage Forms Containing Terbutaline Sulphate In force · High confidence | In force | High confidence | |
| US 12,290,630 | Inhaler Jacket with Cap Attachment In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 31 lapsed for an unpaid fee · 111 ended at full term · 1 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
21 abandoned · 4 no status recorded